IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +78.43% | +0.00% | +0.00% | +0.00% | +55.37% |
| Gross Profit Growth | +119.28% | +0.00% | +0.00% | +0.00% | +52.26% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +33.86% | +17.64% | +13.48% | +4.02% | +1.42% |
| Weighted Average Shares Diluted Growth | +33.86% | +17.64% | +13.48% | +4.06% | +1.42% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -83.33% | -100.00% | -100.00% | -100.00% | +199000.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +73.12% | +14.47% | +6.94% | -4.41% | -1.31% |
| Book Value per Share Growth | +27.39% | -6.92% | -9.23% | -11.07% | -4.77% |
| Debt Growth | +567.51% | +978.85% | +1323.06% | +44.95% | +189.44% |
| R&D Expense Growth | +261.58% | +65.60% | +36.11% | +45.21% | -38.22% |
| SG&A Expenses Growth | +70.62% | +73.49% | +43.56% | +75.95% | +71.16% |